Pesquisa
Educação
Soluções
Entrar
PT
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Medical,
Oral and Biotechnological Sciences,
Center on Advanced Studies and Technology (CAST),
Department of Medical, Oral and Biotechnological Sciences
Mario Romano has not added Biography.
If you are Mario Romano and would like to personalize this page please email our Author Liaison for assistance.
5-lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Nov, 2001 | Pubmed ID: 11689458
Urinary excretion of lipoxin A(4) and related compounds: development of new extraction techniques for lipoxins.
Laboratory investigation; a journal of technical methods and pathology Sep, 2002 | Pubmed ID: 12218086
Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Nov, 2003 | Pubmed ID: 14597668
Lipoxin analogs and lipoxin formation in vivo.
Prostaglandins, leukotrienes, and essential fatty acids , 2005 | Pubmed ID: 15979293
Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins.
Inflammation & allergy drug targets Apr, 2006 | Pubmed ID: 16613567
Lipoxin receptors.
TheScientificWorldJournal Sep, 2007 | Pubmed ID: 17767357
Lipoxin and aspirin-triggered lipoxins.
TheScientificWorldJournal Jun, 2010 | Pubmed ID: 20526535
MicroRNA-181b regulates ALX/FPR2 receptor expression and proresolution signaling in human macrophages.
The Journal of biological chemistry Feb, 2015 | Pubmed ID: 25505240
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation.
European journal of pharmacology Aug, 2015 | Pubmed ID: 25895638
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins.
Stem cells translational medicine Jan, 2016 | Pubmed ID: 26607175
Epigenetic regulation of the formyl peptide receptor 2 gene.
Biochimica et biophysica acta Oct, 2016 | Pubmed ID: 27424221
Immobilization and delivery of biologically active Lipoxin A using electrospinning technology.
International journal of pharmaceutics Dec, 2016 | Pubmed ID: 27732897
Lipoxin A stimulates endothelial miR-126-5p expression and its transfer microvesicles.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology May, 2017 | Pubmed ID: 28100645
Establishment and long-term culture of human cystic fibrosis endothelial cells.
Laboratory investigation; a journal of technical methods and pathology Nov, 2017 | Pubmed ID: 28759010
Mechanisms of endothelial cell dysfunction in cystic fibrosis.
Biochimica et biophysica acta. Molecular basis of disease Dec, 2017 | Pubmed ID: 28847515
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A receptor-dependent mechanisms of inflammation resolution and antimicrobial defense.
Scientific reports Oct, 2017 | Pubmed ID: 29044225
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review.
Stem cells translational medicine Oct, 2019 | Pubmed ID: 31187940
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis.
Frontiers in immunology , 2020 | Pubmed ID: 32528461
The Resolution Approach to Cystic Fibrosis Inflammation.
Frontiers in pharmacology , 2020 | Pubmed ID: 32848748
Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis.
Frontiers in pharmacology , 2021 | Pubmed ID: 34566635
Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society Jul, 2022 | Pubmed ID: 34799298
CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells.
Cells Apr, 2022 | Pubmed ID: 35456026
3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics.
International journal of molecular sciences Sep, 2022 | Pubmed ID: 36077471
“G. d’Annunzio” University of Chieti-Pescara
Roberto Plebani1,2,
Alessandra D'Alessandro2,
Paola Lanuti2,3,
Pasquale Simeone2,3,
Massimiliano Cinalli1,
Ilaria Righi4,
Alessandro Palleschi4,5,
Matteo Mucci1,2,
Marco Marchisio2,3,
Francesco Cappabianca1,
Marina Camera6,7,
Felice Mucilli1,
Mario Romano1,2
1Department of Medical, Oral and Biotechnological Sciences, “G. d’Annunzio” University of Chieti-Pescara,
2Center on Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara,
3Department of Medicine and Aging Sciences, University “G. d’Annunzio” of Chieti-Pescara,
4U.O. di Chirurgia Toracica e dei Trapianti di Polmone, Fondazione IRCCS Ca’ Granda - Ospedale Maggiore Policlinico di Milano,
5Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano,
6Department of Pharmaceutical Sciences, Università degli Studi di Milano,
7Unit of Cell and Molecular Biology in Cardiovascular Diseases, Centro Cardiologico Monzino IRCCS
Privacidade
Termos de uso
Políticas
Entre em contato
recomende à biblioteca
Newsletter
JoVE Journal
Coleções de métodos
JoVE Encyclopedia of Experiments
Arquivo
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de Recursos para Docentes
Autores
Bibliotecários
Acesso
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados